Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
Change company Symbol lookup
Select an option...
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FR First Industrial Realty Trust Inc
PNI PIMCO New York Municipal Income Fund II
NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Closing Price
$0.76
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.78
Day's Low
0.5088
Volume
(Above Average)
Volume:
1,592

10-day average volume:
1,592
1,592

Lifshitz Law PLLC Announces Investigation of MN, PSB, SAIL, and NLSN

6:02 pm ET May 24, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NYSE:MN),(NYSE:PSB),(NYSE:SAIL),(NYSE:NLSN), EQNX::TICKER_END

Manning & Napier, Inc. (NYSE: MN)

Lifshitz Law LLP announces investigation into possible breach of fiduciary duties in connection with the sale of MN to Callodine Group, LLC for $12.85 in cash per share of MN owned.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

PS Business Parks, Inc. (NYSE: PSB)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of PSB to affiliates of Blackstone Real Estate for $187.50 in cash per share of PSB owned.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Sailpoint Technologies Holdings, Inc. (NYSE: SAIL)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of SAIL to Thoma Bravo for $62.25 in cash per share of SAIL owned.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Nielsen Holdings plc (NYSE: NLSN)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of NLSN to a private equity consortium led by Evergreen Coast Capital Corporation and Brookfield Business Partners L.P. for $28.00 in cash per share of NLSN owned.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.(C) 2022 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: info@jlclasslaw.com

https://ml.globenewswire.com/media/NjAxM2RjYmQtN2IxYy00MDkxLTg0MmItZjQ0YjI3N2JkOGFhLTEyMTY1ODk=/tiny/Lifshitz-Law-Firm-P-C-.png

https://ml.globenewswire.com/media/NjAxM2RjYmQtN2IxYy00MDkxLTg0MmItZjQ0YjI3N2JkOGFhLTEyMTY1ODk=/tiny/Lifshitz-Law-Firm-P-C-.png

comtex tracking

COMTEX_407707017/2010/2022-05-24T18:02:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.